Answers are grounded in this paper and cite their sources.
The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.
No takes yet. Share an insight, caveat, or question.
Bhushan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: